The Obama administration's "academic detailing" program - through which representatives from the federal government help doctors select prescription drugs for their patients - is coming under harsh behind-the-scenes criticism from corporate executives including the CEO of Pfizer, who is trying to have the project disbanded.
http://dailycaller.com/2013/04/27/critics-see-conflict-of-interest-as-obama-admin-advises-doctors-on-prescriptions/
http://dailycaller.com/2013/04/27/critics-see-conflict-of-interest-as-obama-admin-advises-doctors-on-prescriptions/
No comments:
Post a Comment